ranolazine has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abacioglu, N; Chukwunyere, U; Sehirli, AO | 1 |
1 other study(ies) available for ranolazine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
COVID-19-related arrhythmias and the possible effects of ranolazine.
Topics: Action Potentials; Angina, Stable; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; COVID-19; COVID-19 Drug Treatment; Cytokines; Hemodynamics; Humans; Inflammation; Potassium Channels; Ranolazine; Sodium Channel Blockers | 2021 |